Alpha Teknova, Inc.
TKNODrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
TKNO Earnings Report
FQ end 2026-06 | Call: 2026-08-05 15:00:00
How TKNO's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AZD3759 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Alpha Teknova, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Alpha Teknova, Inc.'s (TKNO) pipeline across Phase 2. Its lead program is AZD3759 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alpha Teknova, Inc.'s next FDA catalyst?→
Alpha Teknova, Inc.'s (TKNO) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TKNO biotech catalysts?→
Add TKNO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alpha Teknova, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.